Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy.
Garden AS, Dong L, Morrison WH, Stugis EM, Glisson BS, Frank SJ, Beadle BM, Gunn GB, Schwartz DL, Kies MS, Weber RS, Ang KK, Rosenthal DI. Garden AS, et al. Among authors: kies ms. Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):941-7. doi: 10.1016/j.ijrobp.2012.08.004. Epub 2012 Sep 11. Int J Radiat Oncol Biol Phys. 2013. PMID: 22975604
Chemotherapy for skull base cancers.
Diaz EM Jr, Kies MS. Diaz EM Jr, et al. Among authors: kies ms. Otolaryngol Clin North Am. 2001 Dec;34(6):1079-85, viii. doi: 10.1016/s0030-6665(05)70366-2. Otolaryngol Clin North Am. 2001. PMID: 11728933 Review.
Phase II Trial of Induction Chemotherapy for Advanced Sinonasal Squamous Cell Carcinoma.
Contrera KJ, Ferrarotto R, Gunn B, Su SY, Kies MS, Glisson BS, Garden AS, Roberts D, Hanba C, Hoff CO, El-Naggar A, Williams MD, Raza SM, DeMonte F, Chen MM, Chambers MS, Hanna EY. Contrera KJ, et al. Among authors: kies ms. Clin Cancer Res. 2024 Nov 12. doi: 10.1158/1078-0432.CCR-24-1416. Online ahead of print. Clin Cancer Res. 2024. PMID: 39531535
Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234.
Michikawa C, Torres-Saavedra PA, Silver NL, Harari PM, Kies MS, Rosenthal DI, Le QT, Jordan RC, Duose DY, Mallampati S, Trivedi S, Luthra R, Wistuba II, Osman AA, Lichtarge O, Foote RL, Parvathaneni U, Hayes DN, Pickering CR, Myers JN. Michikawa C, et al. Among authors: kies ms. Adv Radiat Oncol. 2022 May 18;7(6):100989. doi: 10.1016/j.adro.2022.100989. eCollection 2022 Nov-Dec. Adv Radiat Oncol. 2022. PMID: 36420184 Free PMC article.
Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study.
Tsimberidou AM, Hong DS, Fu S, Karp DD, Piha-Paul S, Kies MS, Ravi V, Subbiah V, Patel SM, Tu SM, Janku F, Heymach J, Johnson A, Cartwright C, Zhao L, Zhang J, Berry DA, Vining DJ, Futreal A, Miller VA, Meric-Bernstam F. Tsimberidou AM, et al. Among authors: kies ms. NPJ Precis Oncol. 2021 Mar 19;5(1):21. doi: 10.1038/s41698-021-00159-2. NPJ Precis Oncol. 2021. PMID: 33742104 Free PMC article.
A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma.
Gay CM, Zhou Y, Lee JJ, Tang XM, Lu W, Wistuba II, Ferrarotto R, Gibbons DL, Glisson BS, Kies MS, Simon GR, Heymach JV, Tsao AS. Gay CM, et al. Among authors: kies ms. Oncologist. 2020 Oct;25(10):e1457-e1463. doi: 10.1634/theoncologist.2020-0610. Epub 2020 Jul 19. Oncologist. 2020. PMID: 32608142 Free PMC article. Clinical Trial.
Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma.
Haddad RI, Massarelli E, Lee JJ, Lin HY, Hutcheson K, Lewis J, Garden AS, Blumenschein GR, William WN, Pharaon RR, Tishler RB, Glisson BS, Pickering C, Gold KA, Johnson FM, Rabinowits G, Ginsberg LE, Williams MD, Myers J, Kies MS, Papadimitrakopoulou V. Haddad RI, et al. Among authors: kies ms. Ann Oncol. 2019 Mar 1;30(3):471-477. doi: 10.1093/annonc/mdy549. Ann Oncol. 2019. PMID: 30596812 Free PMC article. Clinical Trial.
Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation.
Frank SJ, Blanchard P, Lee JJ, Sturgis EM, Kies MS, Machtay M, Vikram B, Garden AS, Rosenthal DI, Gunn GB, Fuller CD, Hutcheson K, Lai S, Busse PM, Lee NY, Lin A, Foote RL. Frank SJ, et al. Among authors: kies ms. Semin Radiat Oncol. 2018 Apr;28(2):108-113. doi: 10.1016/j.semradonc.2017.12.002. Semin Radiat Oncol. 2018. PMID: 29735186 Free PMC article.
192 results